CompletedPhase 3

The Effect of Lidocaine and Benzocaine on Pain and Injection Satisfaction in Peripheral Intravenous Catheter Application

Turkey (Türkiye)120 participantsStarted 2020-03-04

Plain-language summary

Objective: This research was conducted as a randomized controlled, double-blind experimental study to determine the effect of topical lidocaine and benzocaine on patient's pain and injection satisfaction before peripheral intravenous catheter application. Study Design: The study was completed with 120 individuals who were treated in the green area of a University Hospital Emergency Service and met the inclusion criteria of the study. In collecting research data; Case Report Form (ORF), Baseline Algometer (66 Lb / 30 Kg) and Informed Consent Form were used. Lidocaine Spray, Benzocaine Spray and Alcohol were used in research groups.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Can speak and understand Turkish, * Over the age of 18, * Under the age of 65, * Located in the green area of Erciyes University Emergency Service, * Having orientation in place and time, * Not using psychiatric medication due to any psychiatric illness, * Not using central nervous system drugs, * Does not have any known chronic disease, * No vision or hearing problems, * No signs of phlebitis, scar tissue, dermatitis, incision or infection in the area to be operated, * Does not have pain anywhere on the body that will affect the result of the study and whose visual comparison scale pain score is zero at the time of application * No experience of IV catheter application in the last month, * Not taking analgesic in the last 24 hours, * Intravenous drug treatment is ordered, * With Baseline Algometer device, the average pressure pain threshold is 8-16 pounds (Lb), * Individuals who volunteered to participate in the study and signed the written consent form were included in the study. Exclusion Criteria: * Not wanting to participate in the study, * A history of sensitivity to the study drug or related drugs or any drug excipient, * Having clinically significant vital signs, * Stating that he / she is addicted to alcohol and drugs, * Those who were incompetent or unwilling to comply with the study protocol or who stated that they experienced difficulties in the procedures related to the study (eg establishing vascular access before) were not included in t…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Pain level (Visual Analog Scale)

Timeframe: Evaluation was made immediately after application.

Trial details

NCT IDNCT04859738

SponsorTC Erciyes University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-07-07

View on ClinicalTrials.gov More Peripheral Intravenous Catheterization Application trials